Macrolides
    8.
    发明授权
    Macrolides 失效
    大环内酯类

    公开(公告)号:US06706727B1

    公开(公告)日:2004-03-16

    申请号:US10276622

    申请日:2002-11-18

    IPC分类号: C07D49818

    CPC分类号: C07D498/18

    摘要: The composition of formula I wherein the substituents have various significances, whereby one of R2 to R4 is ethyl. They can be prepared by fermentation, or by replacement of hydroxy with chloro under simultaneous or concomitant epimerization. They are indicated for use as pharmaceuticals in the prevention or treatment of inflammatory conditions and of conditions requiring immunosuppression, optionally in combination or association with further pharmaceutically active and compatible agents, e.g. macrolactam macrolides such as pimecrolimus.

    摘要翻译: 取代基中式I的组成具有各种含义,其中R2至R4中的一个为乙基。 它们可以通过发酵或通过在同时或伴随的差向异构化下用氯代替羟基来制备。 它们被指示用作预防或治疗炎性病症和需要免疫抑制的病症的药物,任选地与其它药学活性和相容性试剂组合或结合,例如, 大环内酰胺大环内酯如吡美莫司。